Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassem Sadek

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 30, 2013
Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanolBassem Sadek, Safa Shehab, Małgorzata Więcek, et al.
Current Pharmaceutical Design|February 1, 2020
Experimental Models for the Discovery of Novel Anticonvulsant Drugs: Focus on Pentylenetetrazole-Induced Seizures and Associated Memory DeficitsAlaa Alachkar, Shreesh K Ojha, Adel Sadeq, et al.
Molecules (Basel, Switzerland)|November 20, 2019
The Neuroprotective Effects of Histamine H3 Receptor Antagonist E177 on Pilocarpine-Induced Status Epilepticus in RatsAlaa Alachkar, Sheikh Azimullah, Shreesh K Ojha, et al.
Epilepsy Research|May 31, 2017
Phenylalanine derivatives with modulating effects on human α1-glycine receptors and anticonvulsant activity in strychnine-induced seizure model in male adult ratsBassem Sadek, Murat Oz, Syed M Nurulain, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum DisorderShilu Deepa Thomas, Hend Abdulaziz Mohammed, Mohammad I K Hamad, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum DisorderShilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, et al.
Journal of Molecular Graphics & Modelling|July 16, 2019
Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocolSara Al Rawashdah, Amar Hamrouni, Bassem Sadek, et al.
Frontiers in Behavioral Neuroscience|February 16, 2026
Simultaneous inhibition of cholinesterase and antagonism of histamine H3 receptors alleviates cognitive deficits and mitigates apoptosis in scopolamine-induced amnesia in miceWajd Ebdah, Shilu Deepa Thomas, Nermin Eissa, et al.
Drug Design, Development and Therapy|December 10, 2016
Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult ratsBassem Sadek, Ali Saad, Gniewomir Latacz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 6, 2017
Nociceptin and the NOP receptor in aversive learning in miceAbdu Adem, Nather Madjid, Ulrika Kahl, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|July 30, 2013
Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanolBassem Sadek, Safa Shehab, Małgorzata Więcek, et al.
Current Pharmaceutical Design|February 1, 2020
Experimental Models for the Discovery of Novel Anticonvulsant Drugs: Focus on Pentylenetetrazole-Induced Seizures and Associated Memory DeficitsAlaa Alachkar, Shreesh K Ojha, Adel Sadeq, et al.
Molecules (Basel, Switzerland)|November 20, 2019
The Neuroprotective Effects of Histamine H3 Receptor Antagonist E177 on Pilocarpine-Induced Status Epilepticus in RatsAlaa Alachkar, Sheikh Azimullah, Shreesh K Ojha, et al.
Epilepsy Research|May 31, 2017
Phenylalanine derivatives with modulating effects on human α1-glycine receptors and anticonvulsant activity in strychnine-induced seizure model in male adult ratsBassem Sadek, Murat Oz, Syed M Nurulain, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum DisorderShilu Deepa Thomas, Hend Abdulaziz Mohammed, Mohammad I K Hamad, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum DisorderShilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, et al.
Journal of Molecular Graphics & Modelling|July 16, 2019
Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocolSara Al Rawashdah, Amar Hamrouni, Bassem Sadek, et al.
Frontiers in Behavioral Neuroscience|February 16, 2026
Simultaneous inhibition of cholinesterase and antagonism of histamine H3 receptors alleviates cognitive deficits and mitigates apoptosis in scopolamine-induced amnesia in miceWajd Ebdah, Shilu Deepa Thomas, Nermin Eissa, et al.
Drug Design, Development and Therapy|December 10, 2016
Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult ratsBassem Sadek, Ali Saad, Gniewomir Latacz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 6, 2017
Nociceptin and the NOP receptor in aversive learning in miceAbdu Adem, Nather Madjid, Ulrika Kahl, et al.
Pageof 10